No. Semaglutide and liraglutide should not be taken together. Both are GLP-1 receptor agonists that act on the same receptor, so combining them adds side effects without adding benefit. The FDA label for Wegovy (revised March 2026) says it’s not recommended alongside any other GLP-1 receptor agonist. What many people actually need is a safe way to switch from one to the other. Here’s why combining them is a problem, how the two drugs compare, and how switching works.
Key takeaways
- Semaglutide and liraglutide are both GLP-1 receptor agonists and should not be used together
- The Wegovy label says combining it with any other GLP-1 drug is not recommended
- Taking both raises the risk of nausea, vomiting, dehydration and, with some diabetes drugs, low blood sugar
- In the STEP 8 trial, semaglutide led to 15.8% weight loss vs 6.4% with liraglutide over 68 weeks
- Switching between the two is common and safe when a provider times it correctly
- Some combinations are fine, such as semaglutide with metformin, but never two GLP-1 drugs at once
Why you shouldn’t take semaglutide and liraglutide together
Semaglutide and liraglutide work the same way. Both mimic GLP-1, a gut hormone that tells your brain you’re full, slows how fast your stomach empties and helps your pancreas release insulin after meals. They bind to the same receptor in the same tissues.
That’s why doubling up doesn’t help. Once the receptor is activated, adding a second drug that targets it doesn’t give you extra appetite control or extra weight loss. It just adds more of the side effects. The main risks are:
- Stronger digestive side effects. Nausea, vomiting, diarrhea and constipation are already common with each drug alone. Together, they’re more likely and more severe.
- Dehydration and kidney strain. Ongoing vomiting or diarrhea can dehydrate you. In some people that leads to sudden kidney problems.
- Low blood sugar. GLP-1 drugs rarely cause lows on their own. But combined with insulin or a sulfonylurea like glipizide, two GLP-1 drugs increase the risk.
- No safety data. No clinical trial has tested the two drugs used together, so their combined risks aren’t known.
The FDA label for Wegovy states that using it with other semaglutide products or any other GLP-1 receptor agonist is not recommended. Medical guidelines take the same approach: if one GLP-1 drug isn’t working well, switch to a different one rather than adding it on top.
Related GLP-1 options: Wegovy · Ozempic · Wegovy pills
Semaglutide vs liraglutide: how they compare
The two drugs are related but not interchangeable. Here’s how they differ:
| Semaglutide | Liraglutide | |
|---|---|---|
| Brand names | Wegovy (weight), Ozempic (diabetes), Rybelsus (oral, diabetes) | Saxenda (weight), Victoza (diabetes) |
| How often | Once a week (injection) or once a day (pill) | Once a day (injection) |
| Half-life | About 1 week | About 13 hours |
| Weight loss dose | Up to 2.4 mg weekly (7.2 mg Wegovy HD for some) | 3.0 mg daily |
| Average weight loss in STEP 8 | 15.8% | 6.4% |
| Generic available | No | Yes, generic Saxenda since 2025 |
The half-life difference matters a lot for switching. Liraglutide clears your body within a day or two. Semaglutide takes several weeks to clear completely. If you want a deeper look at how GLP-1 drugs differ across the whole class, see semaglutide vs other GLP-1 medications.
What the STEP 8 head-to-head trial showed
STEP 8 is the main trial that compared the two drugs directly. It enrolled 338 adults with overweight or obesity but no diabetes, and ran for 68 weeks.
| Result | Semaglutide 2.4 mg weekly | Liraglutide 3.0 mg daily |
|---|---|---|
| Average weight loss | 15.8% | 6.4% |
| Lost 10% or more | 70.9% | 25.6% |
| Lost 15% or more | 55.6% | 12.0% |
| Lost 20% or more | 38.5% | 6.0% |
| Stopped due to side effects | 3.2% | 12.6% |
Digestive side effects were similar in both groups, about 84% vs 83%. But far fewer people stopped semaglutide because of them. This is the main reason many people switch from liraglutide to semaglutide: more weight loss, a once-weekly shot and better staying power.
How to switch from liraglutide to semaglutide safely
Switching is common, but it should be planned with your provider. There’s no official conversion chart, so providers use general principles:
- Stop liraglutide first. Take your last daily dose, then start semaglutide the next day, when your next liraglutide dose would have been due. Because liraglutide clears quickly, there’s no need for a long gap.
- Don’t overlap doses. Taking both “for a few days” isn’t recommended.
- Expect to restart at a lower dose. Many providers start semaglutide at 0.25 mg weekly and increase it every 4 weeks. Some may start higher if you tolerated liraglutide well, but that’s a clinical decision, not a DIY one.
- Watch for a return of nausea. Side effects often come back briefly after each dose increase.
For how the step-up works, see our semaglutide dosing guidelines.
How to switch from semaglutide to liraglutide
Some people move the other way, often because of cost, insurance or side effects. Generic liraglutide for weight loss has been available since August 2025, which has made this switch more common.
Because semaglutide lasts so long in the body, timing matters more here:
- Wait until your next weekly semaglutide dose would be due, about 7 days after your last shot, before starting liraglutide
- Start liraglutide at a low dose, usually 0.6 mg daily, and increase weekly as tolerated up to 3.0 mg
- Expect some leftover semaglutide effect for a few weeks, which is one reason to start low
If you’re new to daily injections, our step-by-step guide on how to properly inject liraglutide walks through the technique.
What to do if you accidentally took both
Mistakes happen, especially during a switch. If you’ve taken both drugs close together:
- Don’t take any more doses of either until you’ve talked to your provider
- Watch for severe or ongoing nausea and vomiting, stomach pain or signs of dehydration (dizziness, very dark urine, little urine)
- If you take insulin or a sulfonylurea, check your blood sugar more often and treat lows promptly
- Get urgent care for severe abdominal pain that spreads to your back, which can signal pancreatitis, or if you can’t keep fluids down
You can also call Poison Control at 1-800-222-1222 for guidance. For warning signs that your dose is too strong in general, see how to know when your GLP-1 dose is too high.
Which combinations with GLP-1 drugs are okay?
The rule is simple: one GLP-1 drug at a time. That also means not combining semaglutide or liraglutide with tirzepatide, which also acts on the GLP-1 receptor.
But GLP-1 drugs can safely be combined with medicines that work in different ways. For example:
- Metformin is often prescribed alongside semaglutide. We cover this in can you take metformin and semaglutide together
- SGLT2 inhibitors such as empagliflozin, which lower blood sugar through the kidneys
- Insulin, with careful dose adjustment to avoid lows
Always give your provider a full list of your medications and supplements so they can check for overlaps.
Should you choose semaglutide or liraglutide?
If your goal is weight loss, semaglutide usually produces much more of it. Liraglutide still has a place:
- Cost. Generic liraglutide may be cheaper than brand semaglutide, depending on insurance and pharmacy.
- Tolerability. Some people who don’t tolerate semaglutide do better on a different GLP-1 drug, or the reverse.
- Faster wash-out. Because liraglutide clears in a day or two, side effects fade faster if you need to stop.
To understand what to expect from liraglutide, read how long liraglutide takes to work. A provider can help you weigh results, cost and side effects for your situation.
The bottom line
Semaglutide and liraglutide should not be taken together. They act on the same receptor, so combining them adds side effects and risks without adding benefit, and the Wegovy label advises against using it with any other GLP-1 drug. If one isn’t working for you, the safer move is to switch, with your provider timing the change and restarting at a low dose. For most people focused on weight loss, semaglutide delivers more results, while generic liraglutide can be a lower-cost option.
Thinking about starting or switching GLP-1 medications? Talk to a Heally provider about a weight loss prescription.
FAQ
Can you take Ozempic and Saxenda together?
No. Ozempic contains semaglutide and Saxenda contains liraglutide, and both are GLP-1 receptor agonists. Using them together increases side effects without extra benefit and isn’t recommended. If you need to change medications, switch from one to the other with your provider’s guidance.
What happens if you take two GLP-1 drugs at once?
You’re more likely to have severe nausea, vomiting, diarrhea and dehydration. If you also take insulin or a sulfonylurea, the risk of low blood sugar goes up. There’s no extra weight loss or blood sugar benefit, because both drugs act on the same receptor.
How do I switch from Saxenda to Wegovy?
Most providers have you stop liraglutide and start semaglutide the next day, often at the 0.25 mg starting dose, then increase every 4 weeks. Don’t overlap the two. Your provider may adjust the starting dose based on how well you tolerated liraglutide.
How long after stopping Wegovy can I start liraglutide?
Usually about a week after your last Wegovy shot, when your next weekly dose would be due. Semaglutide has a half-life of about one week, so some effect lingers. Starting liraglutide at a low dose helps limit side effects.
Is semaglutide better than liraglutide for weight loss?
In the STEP 8 trial, semaglutide led to an average 15.8% weight loss compared with 6.4% for liraglutide over 68 weeks. Fewer people stopped semaglutide because of side effects. It’s also taken once a week instead of daily.
Is there a generic for liraglutide?
Yes. Teva launched the first generic liraglutide for weight management (generic Saxenda) in August 2025, and other manufacturers followed in 2026. There’s no generic semaglutide in the US yet.
Sources
- US Food and Drug Administration. “WEGOVY (semaglutide) prescribing information,” revised March 2026. accessdata.fda.gov
- Rubino DM, et al. “Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.” JAMA, 2022. jamanetwork.com
- Drugs.com. “Generic Saxenda availability.” drugs.com
- Marso SP, et al. “Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes” (LEADER). New England Journal of Medicine, 2016.
This article is for educational purposes only and is not a substitute for professional medical advice. Never combine or switch GLP-1 medications without guidance from a licensed provider. Semaglutide and liraglutide carry an FDA boxed warning about the risk of thyroid C-cell tumors. Do not use them if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
